AzTrials
AzTrials

Total Knee ReplacementTKRNCT03995160

Influence of Closed Suction Drainage After Total Knee Replacement.

A study testing Use of closed suction drainage following total knee arthroplasty and Abstain of using a closed suction drainage in people with Total Knee Replacement, run by Medical University of Warsaw.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The aim of the study will be to compare functional outcomes, basic morphology results, number of blood transfusions, costs of hospitalization, and inflammation factors, following total knee replacement (with use of one type of endoprosthesis) comparing use of closed suction drainage (CSD). Read more about this study

Who is it for?
Ages 50 to 80 years
Conditions the study is for
Total Knee Replacement
What is being tested?
Use of closed suction drainage following total knee arthroplasty and Abstain of using a closed suction drainage
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
No sites listed yet
Study dates
1 Mar 2022to 1 Mar 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 50 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • patient's consent for anticipation in the study
  • arthroplasty in one knee

Who cannot join

  • patient's lack of consent for anticipation in the study
  • haematological diseases
  • reoperations in the area of endoprosthesis
  • medical history of any surgical intervention on the lower limb

Trial locations and contacts

No sites are listed yet.

About this study

Official title: Influence of Closed Suction Drainage After Total Knee Replacement on Patient's Reported Outcome and Basic Morphology Results, and Inflammation Factors

The aim of the study will be to compare functional outcomes, basic morphology results, number of blood transfusions, costs of hospitalization, and inflammation factors, following total knee replacement (with use of one type of endoprosthesis) comparing use of closed suction drainage (CSD). Use of closed suction drainage may have influence on patients functional outcome.

Read the detailed description

Patients with primary knee osteoarthritis will be included in a randomized controlled trial and assigned to total knee arthroplasty with or without closed suction drainage. Subjects will be evaluated preoperatively, 1-day, 3-, 6- and 12-month postoperatively.

Change in morphology results will be measured by comparing preoperative and postoperative levels of haematocrite, haemoglobin, erythrocytes, and platelets.

Change in the number of blood transfusions will be measured by analyzing the number of needed transfusion of packed red blood cells in the postoperative period during stay in the hospital.

Change in levels of inflammation factors will be measured by analyzing the level of C-reactive protein in first and third day postoperatively.

Change in body temperature wille be measured daily by analyzing body temperature from day of the surgery until the day of discharge from the hospital

Presence of haematoma will be evaluated daily in the postoperative period by clinical examination.

Change in Western Ontario and McMasters University Osteoarthritis Index (WOMAC) Pain Score will be measured from baseline (can be measured anytime to a maximum of one month before surgery) 3,6 and 12 months post-operatively

Change in Western Ontario and McMasters University Osteoarthritis Index (WOMAC) Function Score will be measured from baseline (can be measured anytime to a maximum of one month before surgery) 3,6 and 12 months post-operatively

Costs of hospitalization will be measured by comparing cost of hospitalization between two analyzed groups

Being tested
Use of closed suction drainage following total knee arthroplasty, Abstain of using a closed suction drainage
Keywords
total, knee, arthroplasty, tkr, drainage, haematoma
Medical subject headings
Hematoma

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Use of closed suction drainage following total knee arthroplastyProcedure or surgery

    Also called Redon's drain

    Use of closed suction drainage following total knee arthroplasty

  • Abstain of using a closed suction drainageProcedure or surgery

    Abstain of using a closed suction drainage following total knee arthroplasty

Study groups in NCT03995160
Study groupRoleWhat they receive
Total knee replacement with use of closed suction drainageActive comparatorUse of closed suction drainage following total knee replacement in treatment of knee primary osteoarthritis
Receives: Procedure: Use of closed suction drainage following total knee arthroplasty
Total knee replacement without use of closed suction drainageActive comparatorWithout the use of closed suction drainage following total knee replacement in treatment of knee primary osteoarthritis
Receives: Procedure: Abstain of using a closed suction drainage

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in haematocrite levels

    Measuring results of haematocrite (in percentage in 1 ml of blood sample)

    Measured: from baseline (can be measured anytime to a maximum of one month before surgery) to 1-day, 3,6 and 12 months post-operatively

  2. Change in the number of blood transfusions

    Measuring the number of needed transfusion of packed red blood cells in the postoperative period

    Measured: from baseline to the 1-,2-,3- days postoperatively

  3. Change in levels of inflammation factors

    Measuring the level of C-reactive protein

    Measured: from baseline (can be measured anytime to a maximum of one month before surgery) to 1-day, 3,6 and 12 months post-operatively

  4. Change in haemoglobin levels

    Measuring results of haemoglobin (g/dL)

    Measured: from baseline (can be measured anytime to a maximum of one month before surgery) to 1-day, 3,6 and 12 months post-operatively

  5. Change in erythrocytes levels

    Measuring results of erythrocytes (number/ml)

    Measured: from baseline (can be measured anytime to a maximum of one month before surgery) to 1-day, 3,6 and 12 months post-operatively

  6. Change in platelets levels

    Measuring results of platelets (number/ml)

    Measured: from baseline (can be measured anytime to a maximum of one month before surgery) to 1-day, 3,6 and 12 months post-operatively

Secondary outcomes (4)
  1. Change in Western Ontario and McMasters University Osteoarthritis Index (WOMAC) Pain Score from baseline

    The WOMAC Pain score is derived from a sub-section of the Knee injury and Osteoarthritis Outcome Score (KOOS) Knee Survey. The WOMAC Pain scores range from 0-100 with lower scores considered lower pain.

    Measured: from baseline (can be measured anytime to a maximum of one month before surgery) 3,6 and 12 months post-operatively

  2. Change in Western Ontario and McMasters University Osteoarthritis Index (WOMAC) Function Score from baseline

    The WOMAC Function score is derived from a sub-section of the Knee injury and Osteoarthritis Outcome Score (KOOS) Knee Survey. The WOMAC Function scores range from 0-100 with lower scores considered to have better function.

    Measured: from baseline (can be measured anytime to a maximum of one month before surgery) 3,6 and 12 months post-operatively

  3. Change in body temperature

    Measuring body temperature from day of the surgery to the hospital until the day of discharge from the hospital

    Measured: from baseline to the 1-,2-,3- days postoperatively

  4. Influence of using CSD on costs of hospitalization

    Comparing cost of hospitalization between two analyzed groups

    Measured: from baseline to the one year postoperatively

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Jun 2019
  2. Study start1 Mar 2022 (estimated)
  3. Primary completion2 Nov 2022 (estimated)
  4. Study completion1 Mar 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Investigator
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03995160
Sponsor's protocol ID
TKR/ Warsaw MU
Acronym
TKR
Status last verified
Oct 2021
First submitted
25 Apr 2019
Last updated
6 Oct 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Use of closed suction drainage following total knee arthroplasty and Abstain of using a closed suction drainage in people with Total Knee Replacement, run by Medical University of Warsaw.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 6 Oct 2021. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Bartosz Maciąg (+48 881568144, bartosz.maciag94@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in haematocrite levels (time frame: from baseline (can be measured anytime to a maximum of one month before surgery) to 1-day, 3,6 and 12 months post-operatively). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Oct 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in